GANDELLINI, PAOLO
 Distribuzione geografica
Continente #
NA - Nord America 2.038
EU - Europa 1.993
AS - Asia 1.175
OC - Oceania 27
SA - Sud America 14
AF - Africa 12
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.260
Nazione #
US - Stati Uniti d'America 2.010
CN - Cina 617
DE - Germania 574
GB - Regno Unito 490
IT - Italia 378
SE - Svezia 175
SG - Singapore 163
IN - India 130
IE - Irlanda 99
HK - Hong Kong 98
DK - Danimarca 75
FR - Francia 57
ID - Indonesia 41
VN - Vietnam 32
JP - Giappone 27
KR - Corea 27
AU - Australia 26
UA - Ucraina 22
CA - Canada 20
FI - Finlandia 16
NO - Norvegia 16
RU - Federazione Russa 15
BE - Belgio 13
NL - Olanda 13
PL - Polonia 13
TW - Taiwan 11
CH - Svizzera 8
AT - Austria 6
MX - Messico 6
BR - Brasile 5
CO - Colombia 5
ES - Italia 5
IR - Iran 5
MM - Myanmar 5
MY - Malesia 5
SC - Seychelles 5
BD - Bangladesh 4
CL - Cile 4
PT - Portogallo 4
TR - Turchia 4
CZ - Repubblica Ceca 3
EG - Egitto 3
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
GR - Grecia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BZ - Belize 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EU - Europa 1
FJ - Figi 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
IQ - Iraq 1
KE - Kenya 1
MO - Macao, regione amministrativa speciale della Cina 1
OM - Oman 1
PH - Filippine 1
PK - Pakistan 1
RO - Romania 1
TN - Tunisia 1
ZA - Sudafrica 1
ZW - Zimbabwe 1
Totale 5.261
Città #
Frankfurt am Main 469
Southend 348
Fairfield 271
Chandler 223
Milan 174
Houston 148
Wilmington 126
Ashburn 122
Woodbridge 120
Seattle 113
Princeton 103
Dublin 99
Beijing 95
Cambridge 93
Singapore 85
Ann Arbor 78
Dearborn 58
Nanjing 56
Boardman 45
Hong Kong 44
Phoenix 42
Des Moines 36
Jakarta 36
Shanghai 35
Bengaluru 31
Central District 31
Shenyang 28
Guangzhou 26
Dong Ket 22
Berlin 19
Jinan 19
Redwood City 19
Changsha 17
Hebei 17
San Diego 16
Chengdu 15
London 13
Nanchang 13
Tianjin 13
Wuhan 13
Mountain View 11
Seoul 11
Catania 10
Gdansk 10
Hangzhou 10
Los Angeles 10
Madison 10
Xian 10
Brussels 9
Jacksonville 9
New York 9
Zhengzhou 9
Helsinki 8
Jiaxing 8
Ningbo 8
Grafing 7
Taipei 7
Tokyo 7
Bühl 6
Costa Mesa 6
Florence 6
Hackney 6
Hefei 6
Kunming 6
Nottingham 6
Rome 6
Silver Spring 6
Taiyuan 6
Toronto 6
Bogotá 5
Eitensheim 5
Evanston 5
Forlimpopoli 5
Fuzhou 5
Harbin 5
Kilburn 5
Limbiate 5
Mahé 5
Miami 5
Munich 5
New Delhi 5
Newcastle 5
Philadelphia 5
Pittsburgh 5
San Gimignano 5
Taizhou 5
Bergamo 4
Chicago 4
Haikou 4
Hyderabad 4
Kochi 4
Lanzhou 4
Latrobe 4
Lecco 4
Mymensingh 4
Nantes 4
Ottawa 4
Redmond 4
Rotterdam 4
Tappahannock 4
Totale 3.701
Nome #
Reciprocal Metabolic Reprogramming through Lactate Shuttle Coordinately Influences Tumor-Stroma Interplay 389
miR-205 exerts tumor-suppressive functions in human prostate through down-regulation of protein kinase C epsilon 271
LEADeR role of miR-205 host gene as long noncoding RNA in prostate basal cell differentiation 267
MiR-205 enhances radiation sensitivity of prostate cancer cells by impairing DNA damage repair through PKCϵ and ZEB1 inhibition 215
Core Biopsies from Prostate Cancer Patients in Active Surveillance Protocols Harbor PTEN and MYC Alterations 203
Splicing modulation as novel therapeutic strategy against diffuse malignant peritoneal mesothelioma 166
Biological relevance and therapeutic potential of G-quadruplex structures in the human noncoding transcriptome 157
miR-21: an oncomir on strike in prostate cancer 155
Predicting and Understanding Cancer Response to Treatment 151
SPOP deregulation improves the radiation response of prostate cancer models by impairing DNA damage repair 149
Large oncosomes mediate intercellular transfer of functional microRNA 144
Antitumor activity of miR-34a in peritoneal mesothelioma relies on c-MET and AXL inhibition : persistent activation of ERK and AKT signaling as a possible cytoprotective mechanism 136
Coated cationic lipid-nanoparticles entrapping miR-660 inhibit tumor growth in patient-derived xenografts lung cancer models 136
Anti-tumor activity of selective inhibitors of XPO1/CRM1-mediated nuclear export in diffuse malignant peritoneal mesothelioma : the role of survivin 130
Gene expression dataset of prostate cells upon MIR205HG/LEADR modulation 121
miR-1272 Exerts Tumor-Suppressive Functions in Prostate Cancer via HIP1 Suppression 120
Integrated gene and miRNA expression analysis of prostate cancer associated fibroblasts supports a prominent role for interleukin-6 in fibroblast activation 119
miR-205 regulates basement membrane deposition in human prostate: implications for cancer development 114
MiR-205 hinders the malignant interplay between prostate cancer cells and associated fibroblasts 112
MiR-205 impairs the autophagic flux and enhances cisplatin cytotoxicity in castration-resistant prostate cancer cells 111
Prediction of grade reclassification of prostate cancer patients on active surveillance through the combination of a three-mirna signature and selected clinical variables 111
Apollon gene silencing induces apoptosis in breast cancer cells through p53 stabilisation and caspase-3 activation 102
miR-380-5p-mediated repression of TEP1 and TSPYL5 interferes with telomerase activity and favours the emergence of an "ALT-like" phenotype in diffuse malignant peritoneal mesothelioma cells 102
Unveiling the ups and downs of miR-205 in physiology and cancer: transcriptional and post-transcriptional mechanisms 99
Mesenchymal to amoeboid transition is associated with stem-like features of melanoma cells 94
Targeting the telosome: Therapeutic implications 92
Clusterin: A potential target for improving response to antiestrogens 91
Complexity in the tumour microenvironment : cancer associated fibroblast gene expression patterns identify both common and unique features of tumour-stroma crosstalk across cancer types 89
Noncoding RNAs in the interplay between tumor cells and cancer-associated fibroblasts: Signals to catch and targets to hit 83
MicroRNAs in Cancer Management : Big Challenges for Small Molecules 80
miR-875-5p counteracts epithelial-to-mesenchymal transition and enhances radiation response in prostate cancer through repression of the EGFR-ZEB1 axis 70
Potential of the Stromal Matricellular Protein Periostin as a Biomarker to Improve Risk Assessment in Prostate Cancer 60
miRNAs in tumor radiation response : bystanders or participants? 58
Dissecting the role of microRNAs in prostate cancer metastasis : implications for the design of novel therapeutic approaches 57
Oligomer-mediated modulation of hTERT alternative splicing induces telomerase inhibition and cell growth decline in human prostate cancer cells 51
MicroRNAs and the Response of Prostate Cancer to Anti-Cancer Drugs 51
Navigating the Multiverse of Antisense RNAs: The Transcription- and RNA-Dependent Dimension 50
Targeting MicroRNAs to withstand cancer metastasis 49
MicroRNA-dependent Regulation of Telomere Maintenance Mechanisms: A Field as Much Unexplored as Potentially Promising 47
RNA Interference-Mediated Validation of Survivin and Apollon/BRUCE as New Therapeutic Targets for Cancer Therapy 46
Senescent stroma promotes prostate cancer progression : the role of miR-210 44
Emerging Role of microRNAs in Prostate Cancer: Implications for Personalized Medicine 44
Coding the noncoding: 2 years of advances in the field of microRNAs and long noncoding RNAs 44
PKC-alpha modulation by miR-483-3p in platinum-resistant ovarian carcinoma cells 43
microRNAs as players and signals in the metastatic cascade : implications for the development of novel anti-metastatic therapies 43
MicroRNAs: Cobblestones on the road to cancer metastasis 42
MicroRNA-Mediated Control of Prostate Cancer Metastasis: Implications for the Identification of Novel Biomarkers and Therapeutic Targets 42
Antisense oligonucleotide-mediated inhibition of hTERT, but not hTERC, induces rapid cell growth decline and apoptosis in the absence of telomere shortening in human prostate cancer cells 41
Down-regulation of human telomerase reverse transcriptase through specific activation of RNAi pathway quickly results in cancer cell growth impairment 37
MIR205HG/LEADR Long Noncoding RNA Binds to Primed Proximal Regulatory Regions in Prostate Basal Cells Through a Triplex- and Alu-Mediated Mechanism 34
Towards the definition of prostate cancer-related microRNAs: where are we now? 34
MicroRNAs as new therapeutic targets and tools in cancer 32
miR-550a-3p is a prognostic biomarker and exerts tumor-suppressive functions by targeting HSP90AA1 in diffuse malignant peritoneal mesothelioma 30
The pancancer overexpressed NFYC Antisense 1 controls cell cycle mitotic progression through in cis and in trans modes of action 29
MiR-1227 targets SEC23A to regulate the shedding of large extracellular vesicles 29
Photochemically enhanced delivery of a cell-penetrating peptide nucleic acid conjugate targeting human telomerase reverse transcriptase: effects on telomere status and proliferative potential of human prostate cancer cells 27
lncRNAs at the interplay between neurodegeneration and cancer: a role for MINCR 15
Study of lncRNAs in Pediatric Neurological Diseases: Methods, Analysis of the State-of-Art and Possible Therapeutic Implications 15
Functional Study of the Noncoding Regulome of the Nuclear Factor Y 13
Cleavage and polyadenylation machinery as a novel targetable vulnerability for human cancer 12
NFYA alternative cleavage and polyadenylation in cancer 12
Computational analysis of five neurodegenerative diseases reveals shared and specific genetic loci 12
Linc00941 fuels ribogenesis and protein synthesis by supporting robust cMYC translation in Malignant Pleural Mesothelioma 10
NFYC-AS1 antisense lncRNA as a potential novel player in cell cycle regulation in human cancer 10
MicroRNAs in Prostate Cancer: A Possible Role as Novel Biomarkers and Therapeutic Targets? 9
NFYA alternative cleavage and polyadenylation in cancer 9
The pancancer overexpressed and cell cycle regulated NFYC antisense 1 controls tumor E2F/MYC proliferation programs through in cis and in trans modes of action 9
The MYC-induced Long Non-Coding RNA MINCR as a potential novel player in cell cycle regulation in prostate cancer 8
NFYC-AS1 antisense lncRNA as a potential novel player in cell cycle regulation in human cancer 6
NFYA alternative cleavage and polyadenylation in cancer 6
Totale 5.589
Categoria #
all - tutte 17.149
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.149


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.194 138 48 45 160 79 141 119 62 179 118 67 38
2020/2021891 120 76 64 47 59 93 54 50 75 98 65 90
2021/2022685 41 49 35 47 60 30 41 57 85 70 51 119
2022/2023848 111 53 58 71 125 157 21 57 94 7 50 44
2023/20241.255 36 58 39 36 197 53 113 119 66 119 216 203
2024/202590 90 0 0 0 0 0 0 0 0 0 0 0
Totale 5.589